1007-3418
2011 Issue 10
Analysis of clinical correlated factors of primary carcinoma of the liver with and without cirrhosis
SUN Xiao-wen;TAN Wen-ting;TAN Shun;DAN Yun-jie;WANG Sha-sha;DENG Guo-hong
SUN Xiao-wen;TAN Wen-ting;TAN Shun;DAN Yun-jie;WANG Sha-sha;DENG Guo-hong
..............page:793-794
Autonomic dysfunction in liver cirrhosis
WANG Li;ZOU Zhi-qiang
WANG Li;ZOU Zhi-qiang
..............page:798-800
The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C
FAN Xiao-hong;WANG Li-fen;LIU Lin-chang;YAO Hing;SHAN Yuan;LU Hai-ying;WU Chi-hong;XU Xiao-yuan;WEI Lai
FAN Xiao-hong;WANG Li-fen;LIU Lin-chang;YAO Hing;SHAN Yuan;LU Hai-ying;WU Chi-hong;XU Xiao-yuan;WEI Lai
..............page:721-725
The impact of early rapid virological response on the outcomes of hepatitis B associated acute on chronic liver failure during antiviral treatment
CHEN Li;ZHENG Cai-xia;L1N Ming-hua;GAN Qiao-rong;LIN Rong-sheng;GAO Hai-bing;HUANG Jian-rong;PAN Chen
CHEN Li;ZHENG Cai-xia;L1N Ming-hua;GAN Qiao-rong;LIN Rong-sheng;GAO Hai-bing;HUANG Jian-rong;PAN Chen
..............page:734-737
Effect of Saikosaponins-d on reversing malignant phenotype of HepG2 cells in vitro
ZHU Bao-hua;PU Rong;ZHANG Guo-ping;LI Ming-yi;WANG Lan-tian;YUAN Jin-kai
ZHU Bao-hua;PU Rong;ZHANG Guo-ping;LI Ming-yi;WANG Lan-tian;YUAN Jin-kai
..............page:764-767
Comparison of efficacy of pegylated interferon alfa-2a or interferon alfa-2b combination therapy with nucleos(t)ide analogues in HBeAg positive chronic hepatitis B patients
WANG Shu-qiang;XU Kai-ju;WU Jia-zhen;LIUXiao-shu;LUO Ting-ting;YANG Ren-guo;GENG Xiao-xia;HUANG Ren-gang;LIN Jian mei;YANG Xing-xiang;JIANG Nan
WANG Shu-qiang;XU Kai-ju;WU Jia-zhen;LIUXiao-shu;LUO Ting-ting;YANG Ren-guo;GENG Xiao-xia;HUANG Ren-gang;LIN Jian mei;YANG Xing-xiang;JIANG Nan
..............page:785-786
Clinical observation of Qianggan capsule in the treatment of nonalcoholic of non-alcoholic fatty liver fibrosis
GU Sai;HUANG Miao-xing
GU Sai;HUANG Miao-xing
..............page:791-792
The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma
PEI Yan-zhen;HAN Tao;MA Xiao-yan;LI Ying;XING Jing;SONG Zuo-li
PEI Yan-zhen;HAN Tao;MA Xiao-yan;LI Ying;XING Jing;SONG Zuo-li
..............page:743-746
Hepatitis B virus (HBV) subgenotypes and mutations in core promoter and precore/core in Xinjiang Uighur
SUN Xiao-feng;WEN Shu-juan;LIU Hao;HOU Jin-lin;ZHANG Yue-xin;WANG Zhan-hui;ZHENG Yu-jian
SUN Xiao-feng;WEN Shu-juan;LIU Hao;HOU Jin-lin;ZHANG Yue-xin;WANG Zhan-hui;ZHENG Yu-jian
..............page:789-790
Expressions and significance of COX-2 and P-gp in human hepatocellular cacinoma tissues
LI Bo;LIU Yong;SU Song;ZHANG Meng-yu;YAN Qing;CHEN Chuan;XIA Xian-ming;LIU Chang-an;GONG Jian-ping
LI Bo;LIU Yong;SU Song;ZHANG Meng-yu;YAN Qing;CHEN Chuan;XIA Xian-ming;LIU Chang-an;GONG Jian-ping
..............page:755-758
The expression and significance of signal regulatory protein α1 in autoimmune hepatitis
SUN Zheng-qin;HU He-ping;GUO Lin-na;WANG Zhong-juan;WANG Hong-yang;LIU Shu-qin
SUN Zheng-qin;HU He-ping;GUO Lin-na;WANG Zhong-juan;WANG Hong-yang;LIU Shu-qin
..............page:779-781
The role of CTGF in mediating hepatocytes epithelial-to-mesenchymal transition and hepatic fibrogenesis
LI Guang-ming;FAN Jian-gao
LI Guang-ming;FAN Jian-gao
..............page:795-797
Based on the low-density cDNA Macroarray for screening of antiviral proteins of IFNa tissues
GUAN Shi-he;YANG Kai;WANG Qin;CHENG Zhong-le;PAN Ying;WU Yuan-yuan;YANG Dong-liang
GUAN Shi-he;YANG Kai;WANG Qin;CHENG Zhong-le;PAN Ying;WU Yuan-yuan;YANG Dong-liang
..............page:774-778
Effects of HCV core protein on the expression of hypoxia-inducible factor lα and vascular endothelial growth factor
LIU Xing-hui;ZHOU Xin;ZHU Cheng-liang;SONG Hui;LIU Fang
LIU Xing-hui;ZHOU Xin;ZHU Cheng-liang;SONG Hui;LIU Fang
..............page:751-754
Variation and significance of CD4 + CD25 + regulatory T cells in chronic hepatitis B patients complicated with hepatic steatosis
ZHAO Cai-yan;ZHANG Ping-ping;WANG Ya-dong;ZHAO Meng;LU Jian-hua;LIU Zhen-zhong;ZHOU Jun-ying;ZHEN Zhen
ZHAO Cai-yan;ZHANG Ping-ping;WANG Ya-dong;ZHAO Meng;LU Jian-hua;LIU Zhen-zhong;ZHOU Jun-ying;ZHEN Zhen
..............page:787-788
Analysis of hepatitis C virus (HCV) subtypes in HIV/HCV co-infected and HCV mono-infected individuals in Guangdong province
CHEN Wei-lie;NIE Jing-min;CAI Wei-ping;YUAN Xiao-zhen;HU Feng-yu;WEI Shao-jing;TANG Yang-bo;ZHANG Fu-chun;TANG Xiao-ping
CHEN Wei-lie;NIE Jing-min;CAI Wei-ping;YUAN Xiao-zhen;HU Feng-yu;WEI Shao-jing;TANG Yang-bo;ZHANG Fu-chun;TANG Xiao-ping
..............page:729-733
Clinical efficacy and prognostic factors for croyablation patients with advanced hepatocellular carcinoma
CHANG Xiu-juan;LU Yin-ying;BAI Wen-lin;CHEN Yan;AN Lin-jing;ZHOU Lin;WANG Hong;WU Yu;LIU Ze;LOU Min;ZENG Zhen;SU Shu-hui;QU Jian-hui;YANG Yong-ping
CHANG Xiu-juan;LU Yin-ying;BAI Wen-lin;CHEN Yan;AN Lin-jing;ZHOU Lin;WANG Hong;WU Yu;LIU Ze;LOU Min;ZENG Zhen;SU Shu-hui;QU Jian-hui;YANG Yong-ping
..............page:759-763
..............page:前插3,728,733,767,784
Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis
WANG Qi-xia;SHEN Lei;QIU De-kai;BAO Han;CHEN Xiao-yu;ZENG Min-de;MAO Yi-min;MA Xiong
WANG Qi-xia;SHEN Lei;QIU De-kai;BAO Han;CHEN Xiao-yu;ZENG Min-de;MAO Yi-min;MA Xiong
..............page:782-784
Predictors and scoring system for sustained complete response to conventional interferon-α therapy on chronic hepatitis B
HONG Mei-zhu;FANG Kuang-nan;MAO Qian-guo;HUANG Wen-qi;XIA Ting;SONG Min-ning;ZHANG Ru-mian;PAN Jin-shui
HONG Mei-zhu;FANG Kuang-nan;MAO Qian-guo;HUANG Wen-qi;XIA Ting;SONG Min-ning;ZHANG Ru-mian;PAN Jin-shui
..............page:738-742
Detection of core antigen of hepatitis virus C in patients infected with hepatitis virus C and B
CAO Hong;ZHANG Ka;SHU Xin;XU Qi-huan;LI Gang
CAO Hong;ZHANG Ka;SHU Xin;XU Qi-huan;LI Gang
..............page:726-728
Study of the effect and mechanism of spastic paraplegia 21 protein on the replication of hepatitis B virus
GAO Guo-sheng;WENG Peng-jian;LI Yong-yan;DING Shi-xiong
GAO Guo-sheng;WENG Peng-jian;LI Yong-yan;DING Shi-xiong
..............page:747-750
Effect of hepatitis B virus X protein on expression of lipid metabolism-related genes in HepG2 cells
CHEN Juan;SHEN Wei;CHENG Wen-hui
CHEN Juan;SHEN Wei;CHENG Wen-hui
..............page:768-773